170 related articles for article (PubMed ID: 27150557)
1. REM sleep homeostasis in the absence of REM sleep: Effects of antidepressants.
McCarthy A; Wafford K; Shanks E; Ligocki M; Edgar DM; Dijk DJ
Neuropharmacology; 2016 Sep; 108():415-25. PubMed ID: 27150557
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
Gervasoni D; Panconi E; Henninot V; Boissard R; Barbagli B; Fort P; Luppi PH
Pharmacol Biochem Behav; 2002 Oct; 73(3):557-63. PubMed ID: 12151030
[TBL] [Abstract][Full Text] [Related]
3. Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains.
Kostyalik D; Vas S; Kátai Z; Kitka T; Gyertyán I; Bagdy G; Tóthfalusi L
BMC Neurosci; 2014 Nov; 15():120. PubMed ID: 25406958
[TBL] [Abstract][Full Text] [Related]
4. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
[TBL] [Abstract][Full Text] [Related]
5. [Effects of antidepressants on sleep].
Aszalós Z
Orv Hetil; 2006 Apr; 147(17):773-83. PubMed ID: 16780185
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats.
Ivarsson M; Paterson LM; Hutson PH
Eur J Pharmacol; 2005 Oct; 522(1-3):63-71. PubMed ID: 16223479
[TBL] [Abstract][Full Text] [Related]
7. Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep.
Maudhuit C; Jolas T; Chastanet M; Hamon M; Adrien J
Biol Psychiatry; 1996 Nov; 40(10):1000-7. PubMed ID: 8915559
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence and Characteristics of REM Sleep without Atonia (RSWA) in Patients Taking Antidepressants.
Lee K; Baron K; Soca R; Attarian H
J Clin Sleep Med; 2016 Mar; 12(3):351-5. PubMed ID: 26446247
[TBL] [Abstract][Full Text] [Related]
9. Activation of brain-derived neurotrophic factor-tropomyosin receptor kinase B signaling in the pedunculopontine tegmental nucleus: a novel mechanism for the homeostatic regulation of rapid eye movement sleep.
Barnes AK; Koul-Tiwari R; Garner JM; Geist PA; Datta S
J Neurochem; 2017 Apr; 141(1):111-123. PubMed ID: 28027399
[TBL] [Abstract][Full Text] [Related]
10. 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.
Shelton J; Bonaventure P; Li X; Yun S; Lovenberg T; Dugovic C
Neuropharmacology; 2009 Feb; 56(2):448-54. PubMed ID: 18948124
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects in various mice strains in the tail suspension test.
Ripoll N; David DJ; Dailly E; Hascoët M; Bourin M
Behav Brain Res; 2003 Aug; 143(2):193-200. PubMed ID: 12900045
[TBL] [Abstract][Full Text] [Related]
12. Effects of venlafaxine in the sleep architecture of rats.
Salin-Pascual RJ; Moro-Lopez ML
Psychopharmacology (Berl); 1997 Feb; 129(3):295-6. PubMed ID: 9084070
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
14. Dreaming under antidepressants: a systematic review on evidence in depressive patients and healthy volunteers.
Tribl GG; Wetter TC; Schredl M
Sleep Med Rev; 2013 Apr; 17(2):133-42. PubMed ID: 22800769
[TBL] [Abstract][Full Text] [Related]
15. The case against memory consolidation in REM sleep.
Vertes RP; Eastman KE
Behav Brain Sci; 2000 Dec; 23(6):867-76; discussion 904-1121. PubMed ID: 11515146
[TBL] [Abstract][Full Text] [Related]
16. [The effect of antidepressants on the indices of the cardiointervalogram in intact rats and during the deprivation of paradoxical sleep].
Arushenian AE; Semenova FO; Fedulova IV
Eksp Klin Farmakol; 1995; 58(2):29-31. PubMed ID: 7773084
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
[TBL] [Abstract][Full Text] [Related]
18. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
[TBL] [Abstract][Full Text] [Related]
19. Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram.
Wilson SJ; Bailey JE; Rich AS; Adrover M; Potokar J; Nutt DJ
Eur Neuropsychopharmacol; 2004 Oct; 14(5):367-72. PubMed ID: 15336297
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
